iopromide has been researched along with Acute Kidney Failure in 43 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Contrast induced acute kidney injury is one of the most frequent causes of hospital acquired acute kidney injury." | 2.77 | Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial. ( Binder, C; Jaberi, A; Kitzler, TM; Kotanko, P; Petnehazy, E; Rehak, P; Sendlhofer, G; Stacher, R, 2012) |
| " The secondary endpoints are absolute and relative increases in sCr of at least 50%, thrombolysis in myocardial infarction (TIMI) perfusion grade, and major adverse cardiac events at 1, 6, and 12 months." | 2.75 | The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. ( Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C, 2010) |
| "Theophylline levels were within the therapeutic range in patients of the theophylline group during and four hours after CM application (59." | 2.67 | Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. ( Bohle, A; Duda, SH; Erley, CM; Huppert, PE; Koehler, J; Osswald, H; Risler, T; Schlepckow, S; Strohmaier, WL, 1994) |
| "Contrast media can cause acute renal failure by direct toxic effects on the tubular cells and kidney ischemia." | 2.48 | Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy. ( Chicaíza-Becerra, LA; Gamboa, Ó; García-Molina, M, 2012) |
| "Contrast-induced acute kidney injury is a prevalent cause of renal failure, and the noninvasive tools to monitor its progress are lacking." | 1.48 | Application of noninvasive functional imaging to monitor the progressive changes in kidney diffusion and perfusion in contrast-induced acute kidney injury rats at 3.0 T. ( Chen, W; Dong, Y; Guo, B; Lian, Z; Liu, J; Ouyang, F; Zhang, B; Zhang, S, 2018) |
| "A total of 2563 patients diagnosed with STEMI and underwent primary pPCI were retrospectively included in the study." | 1.46 | Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. ( Akdeniz, E; Alper, AT; Bozbay, M; Eren, M; Gumusdag, A; Guvenc, TS; Guzelburc, O; Hayiroglu, MI; Kalenderoglu, K; Oz, A; Tanik, O; Tekkesin, AI; Ugur, M; Velibey, Y, 2017) |
| "Atorvastatin (ATO) was administered intragastrically at the dose of 5, 10 and 30mg/kg/d in different groups, respectively, for 5 days before iopromide injection." | 1.40 | Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway. ( Cai, W; Cao, Y; Chen, X; Li, S; Ma, W; Su, J; Wang, F; Zou, W, 2014) |
| "upon iodixanol injection was reduced almost to the level of iopromide when injecting iodixanol/mannitol (iopromide: 289 ± 68 HU vs iodixanol/mannitol: 343 ± 68 HU)." | 1.38 | The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. ( Ellinghaus, P; Ernst, R; Jost, G; Lengsfeld, P; Lenhard, DC; Pietsch, H; Sieber, MA, 2012) |
| "Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis." | 1.37 | Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (13.95) | 18.2507 |
| 2000's | 12 (27.91) | 29.6817 |
| 2010's | 22 (51.16) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Kalogirou, TE | 1 |
| Meditskou, S | 1 |
| Davidopoulou, S | 1 |
| Savvas, I | 1 |
| Pitoulias, AG | 1 |
| Pitoulias, GA | 1 |
| Lin, HH | 1 |
| Lee, TS | 1 |
| Lin, SJ | 1 |
| Yeh, YC | 1 |
| Lu, TM | 1 |
| Hsu, CP | 1 |
| Chen, F | 1 |
| Lu, J | 1 |
| Yang, X | 1 |
| Xiao, B | 1 |
| Chen, H | 1 |
| Pei, W | 1 |
| Jin, Y | 1 |
| Wang, M | 1 |
| Li, Y | 1 |
| Zhang, J | 1 |
| Liu, F | 1 |
| Gu, G | 1 |
| Cui, W | 1 |
| Liu, C | 1 |
| Hu, YH | 1 |
| Han, Y | 1 |
| Wang, YB | 1 |
| Zhang, Y | 1 |
| Zhang, XQ | 1 |
| He, DF | 1 |
| Ren, HM | 1 |
| Liu, YK | 1 |
| Wang, HY | 1 |
| Tan, T | 1 |
| Lin, PH | 1 |
| Li, HC | 1 |
| Rovin, BH | 1 |
| Ma, JJ | 1 |
| Zeng, CY | 1 |
| Chen, G | 1 |
| Liu, B | 1 |
| Chen, S | 1 |
| Li, H | 2 |
| Liu, J | 3 |
| Mai, Z | 1 |
| Chen, E | 1 |
| Zhou, C | 1 |
| Sun, G | 1 |
| Guo, Z | 1 |
| Lei, L | 1 |
| Huang, S | 1 |
| Zhang, L | 1 |
| Li, M | 1 |
| Tan, N | 2 |
| Liao, Y | 1 |
| Chen, J | 1 |
| Liu, Y | 2 |
| Zhang, B | 1 |
| Dong, Y | 1 |
| Guo, B | 1 |
| Chen, W | 1 |
| Ouyang, F | 1 |
| Lian, Z | 1 |
| Zhang, S | 1 |
| Spasojević-Dimitrijeva, B | 1 |
| Kotur-Stevuljević, J | 1 |
| Đukić, M | 1 |
| Paripović, D | 1 |
| Miloševski-Lomić, G | 1 |
| Spasojević-Kalimanovska, V | 1 |
| Pavićević, P | 1 |
| Mitrović, J | 1 |
| Kostić, M | 1 |
| Azzalini, L | 1 |
| Vilca, LM | 1 |
| Lombardo, F | 1 |
| Poletti, E | 1 |
| Laricchia, A | 1 |
| Beneduce, A | 1 |
| Maccagni, D | 1 |
| Demir, OM | 1 |
| Slavich, M | 1 |
| Giannini, F | 1 |
| Carlino, M | 1 |
| Margonato, A | 1 |
| Cappelletti, A | 1 |
| Colombo, A | 1 |
| Su, J | 1 |
| Zou, W | 1 |
| Cai, W | 1 |
| Chen, X | 1 |
| Wang, F | 1 |
| Li, S | 1 |
| Ma, W | 1 |
| Cao, Y | 1 |
| Wang, YC | 1 |
| Tang, A | 1 |
| Chang, D | 1 |
| Zhang, SJ | 1 |
| Ju, S | 1 |
| Hwang, YJ | 1 |
| Hyun, MC | 1 |
| Choi, BS | 1 |
| Chun, SY | 1 |
| Cho, MH | 1 |
| Mariani, J | 1 |
| Guedes, C | 1 |
| Soares, P | 1 |
| Zalc, S | 1 |
| Campos, CM | 1 |
| Lopes, AC | 1 |
| Spadaro, AG | 1 |
| Perin, MA | 1 |
| Filho, AE | 1 |
| Takimura, CK | 1 |
| Ribeiro, E | 1 |
| Kalil-Filho, R | 1 |
| Edelman, ER | 1 |
| Serruys, PW | 1 |
| Lemos, PA | 1 |
| Liu, YH | 1 |
| Chen, JY | 1 |
| Zhou, YL | 1 |
| Luo, JF | 1 |
| Yu, DQ | 1 |
| Li, LW | 1 |
| Li, HL | 1 |
| Ye, P | 1 |
| Ran, P | 1 |
| Shema-Didi, L | 1 |
| Kristal, B | 1 |
| Eizenberg, S | 1 |
| Marzuq, N | 1 |
| Sussan, M | 1 |
| Feldman-Idov, Y | 1 |
| Ofir, P | 1 |
| Atar, S | 1 |
| Velibey, Y | 1 |
| Oz, A | 1 |
| Tanik, O | 1 |
| Guvenc, TS | 1 |
| Kalenderoglu, K | 1 |
| Gumusdag, A | 1 |
| Akdeniz, E | 1 |
| Bozbay, M | 1 |
| Tekkesin, AI | 1 |
| Guzelburc, O | 1 |
| Hayiroglu, MI | 1 |
| Alper, AT | 1 |
| Ugur, M | 1 |
| Eren, M | 1 |
| Barbieri, L | 1 |
| Verdoia, M | 1 |
| Nardin, M | 1 |
| Marino, P | 1 |
| Suryapranata, H | 1 |
| De Luca, G | 1 |
| Nie, B | 1 |
| Cheng, WJ | 1 |
| Li, YF | 1 |
| Cao, Z | 1 |
| Yang, Q | 1 |
| Zhao, YX | 1 |
| Guo, YH | 1 |
| Zhou, YJ | 1 |
| Heinrich, MC | 1 |
| Häberle, L | 1 |
| Müller, V | 1 |
| Bautz, W | 1 |
| Uder, M | 1 |
| Capasso, P | 1 |
| Weisbord, SD | 1 |
| Bolognese, L | 2 |
| Falsini, G | 2 |
| Grotti, S | 2 |
| Limbruno, U | 2 |
| Liistro, F | 2 |
| Carrera, A | 2 |
| Angioli, P | 2 |
| Picchi, A | 2 |
| Ducci, K | 2 |
| Pierli, C | 2 |
| Serafin, Z | 1 |
| Karolkiewicz, M | 1 |
| Gruszka, M | 1 |
| Strózecki, P | 1 |
| Lasek, W | 1 |
| Odrowaz-Sypniewska, G | 1 |
| Manitius, J | 1 |
| Beuth, W | 1 |
| Wi, J | 1 |
| Ko, YG | 1 |
| Kim, JS | 1 |
| Kim, BK | 1 |
| Choi, D | 1 |
| Ha, JW | 1 |
| Hong, MK | 1 |
| Jang, Y | 1 |
| Cho, HS | 1 |
| Seo, JW | 1 |
| Kang, Y | 1 |
| Bae, EJ | 1 |
| Kim, HJ | 1 |
| Chang, SH | 1 |
| Park, DJ | 1 |
| Schwenke, C | 1 |
| Kitzler, TM | 1 |
| Jaberi, A | 1 |
| Sendlhofer, G | 1 |
| Rehak, P | 1 |
| Binder, C | 1 |
| Petnehazy, E | 1 |
| Stacher, R | 1 |
| Kotanko, P | 1 |
| Lenhard, DC | 1 |
| Pietsch, H | 1 |
| Sieber, MA | 1 |
| Ernst, R | 1 |
| Lengsfeld, P | 1 |
| Ellinghaus, P | 1 |
| Jost, G | 1 |
| Chicaíza-Becerra, LA | 1 |
| García-Molina, M | 1 |
| Gamboa, Ó | 1 |
| Ludwig, U | 1 |
| Connemann, J | 1 |
| Keller, F | 1 |
| MacNeill, BD | 1 |
| Harding, SA | 1 |
| Bazari, H | 1 |
| Patton, KK | 1 |
| Colon-Hernadez, P | 1 |
| DeJoseph, D | 1 |
| Jang, IK | 1 |
| Hsieh, YC | 1 |
| Ting, CT | 1 |
| Liu, TJ | 1 |
| Wang, CL | 1 |
| Chen, YT | 1 |
| Lee, WL | 1 |
| Mueller, C | 1 |
| Seidensticker, P | 1 |
| Buettner, HJ | 1 |
| Perruchoud, AP | 1 |
| Staub, D | 1 |
| Christ, A | 1 |
| Buerkle, G | 1 |
| Kwak, HS | 1 |
| Lee, YH | 1 |
| Han, YM | 1 |
| Jin, GY | 1 |
| Kim, W | 1 |
| Chung, GH | 1 |
| Valente, S | 1 |
| Lazzeri, C | 1 |
| Giglioli, C | 1 |
| Margheri, M | 1 |
| Comeglio, M | 1 |
| Nicolaci, L | 1 |
| Chechi, T | 1 |
| Gensini, GF | 1 |
| Poletti, PA | 1 |
| Saudan, P | 1 |
| Platon, A | 1 |
| Mermillod, B | 1 |
| Sautter, AM | 1 |
| Vermeulen, B | 1 |
| Sarasin, FP | 1 |
| Becker, CD | 1 |
| Martin, PY | 1 |
| Möckel, M | 1 |
| Radovic, M | 1 |
| Kühnle, Y | 1 |
| Combé, V | 1 |
| Waigand, J | 1 |
| Schröder, S | 1 |
| Dietz, R | 1 |
| Frei, U | 1 |
| Eckardt, KU | 1 |
| Wiemer, M | 1 |
| Kreuzpaintner, G | 1 |
| Lauer, B | 1 |
| Kiefel, V | 1 |
| Schultheiss, HP | 1 |
| Horstkotte, D | 1 |
| Strauer, BE | 1 |
| Erley, CM | 1 |
| Duda, SH | 1 |
| Schlepckow, S | 1 |
| Koehler, J | 1 |
| Huppert, PE | 1 |
| Strohmaier, WL | 1 |
| Bohle, A | 1 |
| Risler, T | 1 |
| Osswald, H | 1 |
| Nikonoff, T | 1 |
| Skau, T | 1 |
| Berglund, J | 1 |
| Nyberg, P | 1 |
| Spångberg-Viklund, B | 1 |
| Larsson, R | 1 |
| Liss, P | 2 |
| Nygren, A | 1 |
| Erikson, U | 1 |
| Ulfendahl, HR | 1 |
| Thomsen, HS | 1 |
| Pettersson, G | 1 |
| Towart, R | 1 |
| Grant, D | 1 |
| Thyberg, K | 1 |
| Golman, K | 1 |
| Tervahartiala, P | 1 |
| Kivisaari, L | 1 |
| Kivisaari, R | 1 |
| Virtanen, I | 1 |
| Standertskjöld-Nordenstam, CG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903): A Multicenter, Single-blind, Randomised Controlled Trial[NCT04028323] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-07-16 | Recruiting | ||
| Renal Insufficiency Following Contrast Media Administration Trial IV: Contrast Media Volume Control for Limiting Contrast-Induced Acute Kidney in Acute Coronary Syndrome.[NCT04714736] | 522 participants (Anticipated) | Interventional | 2020-02-10 | Recruiting | |||
| Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study[NCT01947335] | Phase 4 | 83 participants (Actual) | Interventional | 2012-11-30 | Completed | ||
| IVUS Based Ultra-low Volume Contrast Media PCI to Reduce Contrast Induced Nephrology in Patient With Chronic Kidney disease-a Multi-center, Open Label, Randomized Trial (IVUS-CKD)[NCT05913362] | 320 participants (Anticipated) | Interventional | 2023-10-01 | Not yet recruiting | |||
| The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction. The CONTRAST-AMI Study.[NCT00827788] | Phase 4 | 432 participants (Anticipated) | Interventional | 2008-12-31 | Completed | ||
| Department of Geriatrics[NCT02575092] | Phase 2/Phase 3 | 4,000 participants (Actual) | Interventional | 2015-11-01 | Completed | ||
| Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention[NCT03266458] | 210 participants (Anticipated) | Observational [Patient Registry] | 2018-01-01 | Not yet recruiting | |||
| High Dose Atorvastatin Raises Threshold of Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention[NCT04375787] | Phase 4 | 200 participants (Actual) | Interventional | 2020-03-15 | Completed | ||
| Evaluation of the Effect of Dapagliflozin on Cardiac Remodeling in Post Myocardial Infarction Patients[NCT05335629] | 60 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION[NCT00130598] | Phase 2/Phase 3 | 258 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Clinical Controlled Trial to Determinate the Role of Sodium Bicarbonate in the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing to Diagnostic Coronariography and/or Percutaneous Coronary Intervention[NCT00424320] | Phase 3 | 100 participants | Interventional | 2006-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Increase >= 0.5 mg/dl in basal serum creatinine (NCT01947335)
Timeframe: 7 days
| Intervention | percentage of participants (Number) |
|---|---|
| Angiography-guided PCI | 19 |
| IVUS-guided PCI | 7.3 |
Total volume of iodine contrast administered during the index procedure. (NCT01947335)
Timeframe: Day 1
| Intervention | ml (Median) |
|---|---|
| Angiography-guided PCI | 64.5 |
| IVUS-guided PCI | 20.0 |
Composite of death, myocardial infarction or repeat revascularization (NCT01947335)
Timeframe: 30 days and 6 months
| Intervention | participants (Number) | |
|---|---|---|
| 30 days | 6-months | |
| Angiography-guided PCI | 2 | 2 |
| IVUS-guided PCI | 2 | 5 |
2 reviews available for iopromide and Acute Kidney Failure
| Article | Year |
|---|---|
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Confidence Intervals; Contrast Media; Creatinine | 2009 |
Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
Topics: Acute Kidney Injury; Aged; Colombia; Contrast Media; Cost-Benefit Analysis; Decision Trees; Drug Cos | 2012 |
12 trials available for iopromide and Acute Kidney Failure
29 other studies available for iopromide and Acute Kidney Failure
| Article | Year |
|---|---|
Investigating the Possible Protective Role of Direct Intra-arterial Administration of Mannitol and N-Acetylcysteine and Per Os Administration of Simvastatin Against Contrast-Induced Nephropathy: An Experimental Study in a Rabbit Model.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Animals; Contrast Media; Disease Models, | 2019 |
DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
Topics: Acute Kidney Injury; Amidohydrolases; Animals; Arginine; Cell Line; Contrast Media; Female; Humans; | 2019 |
Acetylbritannilactone attenuates contrast-induced acute kidney injury through its anti-pyroptosis effects.
Topics: Acute Kidney Injury; Animals; Apoptosis Regulatory Proteins; Cell Line; Disease Models, Animal; Epit | 2020 |
MG53 protects against contrast-induced acute kidney injury by reducing cell membrane damage and apoptosis.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Membrane; Epithelial Cells; Female; Humans; Iohexol; K | 2020 |
Novel biomarkers for post-contrast acute kidney injury identified from long non-coding RNA expression profiles.
Topics: Acute Kidney Injury; Aged; Animals; Biomarkers; Contrast Media; Disease Models, Animal; Female; Gene | 2021 |
Application of noninvasive functional imaging to monitor the progressive changes in kidney diffusion and perfusion in contrast-induced acute kidney injury rats at 3.0 T.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Progress | 2018 |
Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Functio
Topics: Acute Kidney Injury; Adolescent; Biomarkers; Case-Control Studies; Child; Child, Preschool; Contrast | 2017 |
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Humans; Incide | 2018 |
Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway.
Topics: Acute Kidney Injury; Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Contra | 2014 |
Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and com
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Contrast Media; Diffusion Magnetic Resonance Ima | 2014 |
Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Occlusion; Female; Glomerular Filtration Rate; H | 2015 |
Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Biomarkers; Blood Platelets; Contrast Media; Creatinine; Female; Humans; Iohexo | 2017 |
Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Incidence; Iohexol; | 2017 |
Comment on meta-analyses of trials comparing contrast media.
Topics: Acute Kidney Injury; Aged; Cardiac Catheterization; Confidence Intervals; Contrast Media; Creatinine | 2009 |
Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Adult; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progressio | 2011 |
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media | 2011 |
The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Topics: Acute Kidney Injury; Animals; Biomarkers; Contrast Media; Iohexol; Kidney; Male; Mannitol; Osmolar C | 2012 |
Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
Topics: Acute Kidney Injury; Cell Line; Contrast Media; DNA Fragmentation; Humans; Iohexol; Kidney; Osmolar | 2013 |
Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency.
Topics: Acute Kidney Injury; Aged; Angina, Unstable; Cardiac Catheterization; Contrast Media; Coronary Angio | 2005 |
Comparison of renal damage by iodinated contrast or gadolinium in an acute renal failure rat model based on serum creatinine levels and apoptosis degree.
Topics: Acute Kidney Injury; Animals; Apoptosis; Contrast Media; Creatine; Female; Gadolinium DTPA; Iohexol; | 2005 |
Contrast-induced nephropathy in urgent coronary interventions.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; | 2006 |
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Topics: Acute Kidney Injury; Aged; Blood Flow Velocity; Contrast Media; Coronary Angiography; Creatinine; Fe | 2008 |
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection].
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Contrast Media; | 1995 |
Effects of femoral arteriography and low osmolar contrast agents on renal function.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiography; Contrast Media; Diabetes Mellitus; | 1993 |
Effects of contrast media on renal microcirculation and oxygen tension. An experimental study in the rat.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diuretics; Erythrocyte Aggregation; Iohexol; Kidney; M | 1997 |
Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla.
Topics: Acute Kidney Injury; Animals; Contrast Media; Hypoxia; Injections, Intravenous; Iohexol; Ioxaglic Ac | 1998 |
Contrast-medium-induced nephrotoxicity: are all answers in for acetylcysteine?
Topics: Acetylcysteine; Acute Kidney Injury; Combined Modality Therapy; Contrast Media; Double-Blind Method; | 2001 |
The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
Topics: Acute Kidney Injury; Animals; Contrast Media; Injections, Intravenous; Iohexol; Iopamidol; Kidney; L | 2002 |
Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diatrizoate; Female; Gadolinium DTPA; Iohexol; Kidney | 1991 |